Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 38
Filtrer
1.
Phys Rev Lett ; 120(13): 132505, 2018 Mar 30.
Article de Anglais | MEDLINE | ID: mdl-29694189

RÉSUMÉ

We report on the first observation of γ rays emitted from an sd-shell hypernucleus, _{Λ}^{19}F. The energy spacing between the ground state doublet, 1/2^{+} and 3/2^{+} states, of _{Λ}^{19}F is determined to be 315.5±0.4(stat)_{-0.5}^{+0.6}(syst) keV by measuring the γ-ray energy of the M1(3/2^{+}→1/2^{+}) transition. In addition, three γ-ray peaks are observed and assigned as E2(5/2^{+}→1/2^{+}), E1(1/2^{-}→1/2^{+}), and E1(1/2^{-}→3/2^{+}) transitions. The excitation energies of the 5/2^{+} and 1/2^{-} states are determined to be 895.2±0.3(stat)±0.5(syst) and 1265.6±1.2(stat)_{-0.5}^{+0.7}(syst) keV, respectively. It is found that the ground state doublet spacing is well described by theoretical models based on existing s- and p-shell hypernuclear data.

2.
Cell Death Dis ; 7: e2230, 2016 05 19.
Article de Anglais | MEDLINE | ID: mdl-27195677

RÉSUMÉ

The kinase suppressor of Ras 1 (KSR1) has a fundamental role in mitogenic signaling by scaffolding components of the Ras/MAP kinase pathway. In response to Ras activation, KSR1 assembles a tripartite kinase complex that optimally transfers signals generated at the cell membrane to activate ERK. We describe a novel mechanism of ERK attenuation based on ubiquitin-dependent proteolysis of KSR1. Stimulation of membrane receptors by hormones or growth factors induced KSR1 polyubiquitination, which paralleled a decline of ERK1/2 signaling. We identified praja2 as the E3 ligase that ubiquitylates KSR1. We showed that praja2-dependent regulation of KSR1 is involved in the growth of cancer cells and in the maintenance of undifferentiated pluripotent state in mouse embryonic stem cells. The dynamic interplay between the ubiquitin system and the kinase scaffold of the Ras pathway shapes the activation profile of the mitogenic cascade. By controlling KSR1 levels, praja2 directly affects compartmentalized ERK activities, impacting on physiological events required for cell proliferation and maintenance of embryonic stem cell pluripotency.


Sujet(s)
Mitogen-Activated Protein Kinase 1/génétique , Mitogen-Activated Protein Kinase 3/génétique , Protein kinases/génétique , Transduction du signal , Ubiquitin-protein ligases/génétique , Séquence d'acides aminés , Animaux , Lignée cellulaire tumorale , Prolifération cellulaire , Colforsine/pharmacologie , Facteur de croissance épidermique/pharmacologie , Facteur de croissance fibroblastique de type 2/pharmacologie , Régulation de l'expression des gènes , Cellules HEK293 , Humains , Souris , Mitogen-Activated Protein Kinase 1/métabolisme , Mitogen-Activated Protein Kinase 3/métabolisme , Mitogènes/pharmacologie , Modèles moléculaires , Cellules souches embryonnaires de souris/cytologie , Cellules souches embryonnaires de souris/effets des médicaments et des substances chimiques , Cellules souches embryonnaires de souris/métabolisme , Névroglie/effets des médicaments et des substances chimiques , Névroglie/métabolisme , Névroglie/anatomopathologie , Ostéoblastes/effets des médicaments et des substances chimiques , Ostéoblastes/métabolisme , Ostéoblastes/anatomopathologie , Protein kinases/composition chimique , Protein kinases/métabolisme , Stabilité protéique , Protéolyse , Alignement de séquences , Similitude structurale de protéines , Ubiquitin-protein ligases/métabolisme , Ubiquitination
3.
Phys Rev Lett ; 115(22): 222501, 2015 Nov 27.
Article de Anglais | MEDLINE | ID: mdl-26650298

RÉSUMÉ

The energy spacing between the spin-doublet bound state of _{Λ}^{4}He(1^{+},0^{+}) was determined to be 1406±2±2 keV, by measuring γ rays for the 1^{+}→0^{+} transition with a high efficiency germanium detector array in coincidence with the ^{4}He(K^{-},π^{-})_{Λ}^{4}He reaction at J-PARC. In comparison to the corresponding energy spacing in the mirror hypernucleus _{Λ}^{4}H, the present result clearly indicates the existence of charge symmetry breaking (CSB) in ΛN interaction. By combining the energy spacings with the known ground-state binding energies, it is also found that the CSB effect is large in the 0^{+} ground state but is vanishingly small in the 1^{+} excited state, demonstrating that the ΛN CSB interaction has spin dependence.

4.
Rep Prog Phys ; 78(9): 096301, 2015 Sep.
Article de Anglais | MEDLINE | ID: mdl-26317857

RÉSUMÉ

Since the shutdown of several old proton synchrotrons, which played a fundamental role in the second generation experiments in hypernuclear physics performed in Europe, USA and Japan, some new experimental setups aiming to achieve sub-MeV energy resolution have been operating for a long time. Over the last decade the hypernuclear physics community has been committed to carrying out several third generation experiments by exploiting the potential offered by new accelerators, such as a continuous electron beam machine and a ϕ-factory. Large data samples were collected on specific items thanks to dedicated facilities and experimental apparatuses. The attention was mainly focused on both high-resolution spectroscopy and the decay mode study of single Λ-hypernuclei. Nowadays this phase is over but, until recently, important and, to some extent, unexpected results were achieved. An updated review of selected experimental results is presented, as well as a survey of perspectives for future studies.

5.
Phys Rev Lett ; 109(13): 132002, 2012 Sep 28.
Article de Anglais | MEDLINE | ID: mdl-23030084

RÉSUMÉ

The Θ(+) pentaquark baryon was searched for via the π(-)p→K(-)X reaction with a missing mass resolution of 1.4 MeV/c(2) (FWHM) at the Japan Proton Accelerator Research Complex (J-PARC). π(-) meson beams were incident on the liquid hydrogen target with a beam momentum of 1.92 GeV/c. No peak structure corresponding to the Θ(+) mass was observed. The upper limit of the production cross section averaged over the scattering angle of 2° to 15° in the laboratory frame is obtained to be 0.26 µb/sr in the mass region of 1.51-1.55 GeV/c(2). The upper limit of the Θ(+) decay width is obtained to be 0.72 and 3.1 MeV for J(Θ)(P)=1/2(+) and J(Θ)(P)=1/2(-), respectively, using the effective Lagrangian approach.

6.
Phys Rev Lett ; 108(4): 042501, 2012 Jan 27.
Article de Anglais | MEDLINE | ID: mdl-22400828

RÉSUMÉ

Evidence for the neutron-rich hypernucleus (Λ)(6)H is presented from the FINUDA experiment at DAΦNE, Frascati, studying (π+,π-) pairs in coincidence from the K(stop)(-) + (6)Li →(Λ)(6)H + π+ production reaction followed by (Λ)(6)H → (6)He + π- weak decay. The production rate of (Λ)(6) undergoing this two-body π- decay is determined to be (2.9 ± 2.0) × 10(-6)/K(stop)(-). Its binding energy, evaluated jointly from production and decay, is BΛ((Λ)(6)H) = (4.0 ± 1.1) MeV with respect to (5)H+Λ. A systematic difference of (0.98 ± 0.74) MeV between BΛ values derived separately from decay and from production is tentatively assigned to the (Λ)(6)H 0(g.s.)(+) → 1+ excitation.

7.
Oncogene ; 26(14): 2095-103, 2007 Mar 29.
Article de Anglais | MEDLINE | ID: mdl-17016431

RÉSUMÉ

Cyclic adenosine 3'5' monophosphate (cAMP) and protein kinase A (PKA) cooperate with phosphatidylinositol 3' kinase (PI3K) signals in the control of growth and survival. To determine the molecular mechanism(s) involved, we identified and mutagenized a specific serine (residue 83) in p85alpha(PI3K), which is phosphorylated in vivo and in vitro by PKA. Expression of p85alpha(PI3K) mutants (alanine or aspartic substitutions) significantly altered the biological responses of the cells to cAMP. cAMP protection from anoikis was reduced in cells expressing the alanine version p85alpha(PI3K). These cells did not arrest in G1 in the presence of cAMP, whereas cells expressing the aspartic mutant p85D accumulated in G1 even in the absence of cAMP. S phase was still efficiently inhibited by cAMP in cells expressing both mutants. The binding of PI3K to Ras p21 was greatly reduced in cells expressing p85A in the presence or absence of cAMP. Conversely, expression of the aspartic mutant stimulated robustly the binding of PI3K to p21 Ras in the presence of cAMP. Mutation in the Ser 83 inhibited cAMP, but not PDGF stimulation of PI3K. Conversely, the p85D aspartic mutant amplified cAMP stimulation of PI3K activity. Phosphorylation of Ser 83 by cAMP-PKA in p85alpha(PI3K) was also necessary for estrogen signaling as expression of p85A or p85D mutants inhibited or amplified, respectively, the binding of estrogen receptor to p85alpha and AKT phosphorylation induced by estrogens. The data presented indicate that: (1) phosphorylation of Ser 83 in p85alpha(PI3K) is critical for cAMP-PKA induced G1 arrest and survival in mouse 3T3 fibroblasts; (2) this site is necessary for amplification of estrogen signals by cAMP-PKA and related receptors. Finally, these data suggest a general mechanism of PI3K regulation by cAMP, operating in various cell types and under different conditions.


Sujet(s)
Cyclic AMP-Dependent Protein Kinases/métabolisme , AMP cyclique/pharmacologie , Oestrogènes/pharmacologie , Phosphatidylinositol 3-kinases/métabolisme , Transduction du signal , Animaux , Prolifération cellulaire/effets des médicaments et des substances chimiques , Survie cellulaire/génétique , Cellules cultivées , Cytoprotection , Oestrogènes/métabolisme , Phase G1/effets des médicaments et des substances chimiques , Phase G1/génétique , Humains , Mutation , Phosphatidylinositol 3-kinases/génétique , Phosphorylation , Facteur de croissance dérivé des plaquettes/pharmacologie , Protéines proto-oncogènes p21(ras)/métabolisme , Sérine/génétique , Sérine/métabolisme
8.
Phys Rev Lett ; 94(21): 212303, 2005 Jun 03.
Article de Anglais | MEDLINE | ID: mdl-16090313

RÉSUMÉ

We have searched for a deeply bound kaonic state by using the FINUDA spectrometer installed at the e(+)e(-) collider DAPhiNE. Almost monochromatic K(-)'s produced through the decay of phi(1020) mesons are used to observe K(-) absorption reactions stopped on very thin nuclear targets. Taking this unique advantage, we have succeeded to detect a kaon-bound state K(-)pp through its two-body decay into a Lambda hyperon and a proton. The binding energy and the decay width are determined from the invariant-mass distribution as 115(+6)(-5)(stat)(+3)(-4)(syst) MeV and 67(+14)(-11)(stat)(+2)(-3)(syst) MeV, respectively.

9.
Am J Rhinol ; 15(5): 297-301, 2001.
Article de Anglais | MEDLINE | ID: mdl-11732814

RÉSUMÉ

Cold-induced rhinitis (CIR) is common among skiers and is perceived as a troublesome disease. We studied the clinical characteristics of CIR in a population of skiers and we evaluated the effectiveness of ipratropium bromide nasal spray (IBNS) in relieving symptoms in a double-blind placebo-controlled fashion. By means of specific questionnaires, we evaluated 144 subjects (69% men; mean age, 42.2 years). The prevalence of CIR was 48.6% and the distinctive symptom was rhinorrhea (96%), often severe. The prevalence of atopy was higher in the CIR patients (chi2; p = 0.004). Twenty-eight CIR subjects participated in a double-blind placebo-controlled cross-over trial for evaluating the effectiveness of IBNS (80 microg twice per day [b.i.d.]). The severity of symptoms was assessed by a visual analog scale, and the number of cleaning tissues used also was evaluated. The actively treated group showed a significant improvement of rhinorrhea (p = 0.0007) and a reduction in the number of cleaning tissues used (p = 0.0023). Only four mild local side effects were reported. We conclude that IBNS could be regarded as an optimal therapeutic option for treating CIR symptoms in skiers.


Sujet(s)
Antagonistes cholinergiques/usage thérapeutique , Ipratropium/usage thérapeutique , Rhinite/traitement médicamenteux , Ski , Adolescent , Adulte , Basse température/effets indésirables , Études croisées , Méthode en double aveugle , Femelle , Humains , Mâle , Adulte d'âge moyen , Rhinite/étiologie
10.
J Neurosci ; 21(22): 8842-53, 2001 Nov 15.
Article de Anglais | MEDLINE | ID: mdl-11698596

RÉSUMÉ

The vasoconstrictor peptide endothelin (ET-1) exerts its physiological and pathological effects via activation of ET(A) and ET(B) receptor (ET-R) subtypes. In this study, we demonstrate that both ET-R subtypes are highly expressed in rat astrocytes in vivo, indicating that these cells are potential targets of the biological effects of ET-1 in the brain. In cultured cortical astrocytes, both ET-R subtypes are expressed, and selective stimulation of ET(B)-R with ET-1 induces phosphorylation of cAMP response element-binding protein (CREB). The signal transduction pathway activated by ET-1 includes the Rap1/B-Raf and the Ras/Raf-1 complexes, protein kinase C (PKC) together with extracellular signal-regulated kinases (ERK), and the ribosomal S6 kinase (RSK) isoforms RSK2 and RSK3, two kinases that lie immediately downstream of ERK and are able to phosphorylate CREB. Moreover, ET-1 activates the p38 mitogen-activated protein kinase (MAPK)-dependent, but not the c-jun N-terminal kinase (JNK)-dependent pathway. By using selective protein kinase inhibitors and expression of dominant-negative Rap1 protein, we also found that the Rap1/PKC/ERK-dependent pathway induces the phosphorylation of activating transcription factor-1, CREB, and Elk-1, whereas the p38MAPK-dependent pathway only causes CREB phosphorylation. ET-1-induced transcription of the immediate early gene c-fos requires the concomitant activation of both the PKC/ERK- and p38MAPK-dependent pathways, because inhibitors of either pathway block the ET-1-induced increase of c-fos mRNA. Our findings indicate that changes in the expression of cAMP response element-dependent immediate and delayed response genes could play a pivotal role in the physiological effects elicited by ET-1 in astrocytes.


Sujet(s)
Astrocytes/métabolisme , Protéine de liaison à l'élément de réponse à l'AMP cyclique/métabolisme , Protéines de liaison à l'ADN , Mitogen-Activated Protein Kinases/métabolisme , Protéines proto-oncogènes c-fos/biosynthèse , Récepteur endothéline/métabolisme , Transduction du signal/physiologie , Facteur de transcription ATF-1 , Animaux , Astrocytes/cytologie , Astrocytes/effets des médicaments et des substances chimiques , Cellules cultivées , Endothéline-1/pharmacologie , Phosphorylation/effets des médicaments et des substances chimiques , Protéine kinase C/métabolisme , Protéines proto-oncogènes B-raf , Protéines proto-oncogènes c-fos/génétique , Protéines proto-oncogènes c-raf/métabolisme , ARN messager/métabolisme , Rats , Rat Sprague-Dawley , Récepteur de type A de l'endothéline , Récepteur de l'endothéline de type B , Transduction du signal/effets des médicaments et des substances chimiques , Facteurs de transcription/métabolisme , p38 Mitogen-Activated Protein Kinases , Protéines G rap1/biosynthèse , Protéines G rap1/génétique
11.
Minerva Chir ; 56(4): 383-91, 2001 Aug.
Article de Italien | MEDLINE | ID: mdl-11460074

RÉSUMÉ

Chronic venous insufficiency is a recurrent pathology, but affected patients often undergo clinical observation at a most severe and clearly symptomatic stage of the disease. In this late stage, therapy can only relieve symptoms of the disease which often lead to disability. In the clinical course of chronic venous insufficiency, phlebostatic ulceration constitutes a recurrent finding and it is responsible of compromising patients quality of life. The role of perforating veins, made refluxive by various pathogenic noxa, in the genesis of ulcerative lesions has been known since long time. For many years the interest in perforating veins surgery has been limited because of the several negative consequences of the operations. The possibility of modifying the hemodynamics of perforating veins compartment without causing post-operation complications by video-supported surgery, led to the debate on the role of these vessels in the chronic venous insufficiency. The phlebostasis non-invasive diagnosis uses imaging techniques consisting in tests which mostly are cheap, simple and easy to perform, thus representing the best early approach to the patient. It is widely thought that even though complex examinations are available, most precious information can be obtained by only two examinations: color-Doppler ultrasonography and, limitedly, plethysmography. By these diagnostic directions it is possible to better identify the site and the hemodynamic origin of the venous insufficiency.


Sujet(s)
Angioscopie/méthodes , Ulcère de la jambe/chirurgie , Insuffisance veineuse/chirurgie , Fascia , Humains , Ulcère de la jambe/diagnostic , Ulcère de la jambe/physiopathologie , Insuffisance veineuse/diagnostic , Insuffisance veineuse/physiopathologie
12.
J Mol Biol ; 308(2): 99-114, 2001 Apr 27.
Article de Anglais | MEDLINE | ID: mdl-11327755

RÉSUMÉ

cAMP-dependent protein kinase is targeted to discrete subcellular locations by a family of specific anchor proteins (A-kinase anchor proteins, AKAPs). Localization recruits protein kinase A (PKA) holoenzyme close to its substrate/effector proteins, directing and amplifying the biological effects of cAMP signaling.AKAPs include two conserved structural modules: (i) a targeting domain that serves as a scaffold and membrane anchor; and (ii) a tethering domain that interacts with PKA regulatory subunits. Alternative splicing can shuffle targeting and tethering domains to generate a variety of AKAPs with different targeting specificity. Although AKAPs have been identified on the basis of their interaction with PKA, they also bind other signaling molecules, mainly phosphatases and kinases, that regulate AKAP targeting and activate other signal transduction pathways. We suggest that AKAP forms a "transduceosome" by acting as an autonomous multivalent scaffold that assembles and integrates signals derived from multiple pathways. The transduceosome amplifies cAMP and other signals locally and, by stabilizing and reducing the basal activity of PKA, it also exerts long-distance effects. The AKAP transduceosome thus optimizes the amplitude and the signal/noise ratio of cAMP-PKA stimuli travelling from the membrane to the nucleus and other subcellular compartments.


Sujet(s)
Protéines adaptatrices de la transduction du signal , Protéines de transport/métabolisme , Cyclic AMP-Dependent Protein Kinases/métabolisme , Protéines d'ancrage aux protéines kinases A , Séquence d'acides aminés , Animaux , Protéines de transport/composition chimique , Membrane cellulaire/métabolisme , Noyau de la cellule/métabolisme , Centrosome/métabolisme , Cyclic AMP-Dependent Protein Kinases/composition chimique , Cytosquelette/métabolisme , Réticulum endoplasmique/métabolisme , Humains , Mitochondries/métabolisme , Données de séquences moléculaires , Péroxysomes/métabolisme , Récepteurs de surface cellulaire/métabolisme , Transduction du signal
13.
Curr Biol ; 11(8): 614-9, 2001 Apr 17.
Article de Anglais | MEDLINE | ID: mdl-11369207

RÉSUMÉ

Ras p21 signaling is involved in multiple aspects of growth, differentiation, and stress response [1-2]. There is evidence pointing to superoxides as relays of Ras signaling messages. Chemicals with antioxidant activity suppress Ras-induced DNA synthesis. The inhibition of Ras significantly reduces the production of superoxides by the NADPH-oxidase complex [3]. Kirsten and Harvey are nonallelic Ras cellular genes that share a high degree of structural and functional homology. The sequences of Ki- and Ha-Ras proteins are almost identical. They diverge only in the 20-amino acid hypervariable domain at the COOH termini. To date, their functions remain indistinguishable [4]. We show that Ki- and Ha-Ras genes differently regulate the redox state of the cell. Ha-Ras-expressing cells produce high levels of reactive oxygen species (ROS) by inducing the NADPH-oxidase system. Ki-Ras, on the other hand, stimulates the scavenging of ROS by activating posttranscriptionally the mitochondrial antioxidant enzyme, Mn-superoxide dismutase (Mn-SOD), via an ERK1/2-dependent pathway. Glutamic acid substitution of the four lysine residues in the polybasic stretch at the COOH terminus of Ki-Ras completely abolishes the activation of Mn-SOD, although it does not inhibit ERK1/2-induced transcription. In contrast, an alanine substitution of the cysteine of the CAAX box has very little effect on Mn-SOD activity but eliminates ERK1/2- dependent transcription.


Sujet(s)
Gènes ras/physiologie , Transduction du signal/physiologie , Cellules 3T3 , Animaux , Cellules COS , Lignée cellulaire , Chlorocebus aethiops , Souris , Mitogen-Activated Protein Kinase 1/antagonistes et inhibiteurs , Mitogen-Activated Protein Kinase 1/métabolisme , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinases/antagonistes et inhibiteurs , Mitogen-Activated Protein Kinases/métabolisme , Oxydoréduction , Phosphatidylinositol 3-kinases/métabolisme , Inhibiteurs des phosphoinositide-3 kinases , Protéines proto-oncogènes p21(ras)/génétique , Protéines proto-oncogènes p21(ras)/métabolisme , Rats , Espèces réactives de l'oxygène/métabolisme , Superoxide dismutase/métabolisme
14.
Gene ; 267(1): 89-93, 2001 Apr 04.
Article de Anglais | MEDLINE | ID: mdl-11311558

RÉSUMÉ

Spinocerebellar ataxia 2 (SCA-2) is a neurodegenerative disorder caused by the expansion of an unstable CAG/polyglutamine repeat located at the NH(2)-terminus of ataxin-2 protein. Ataxin-2 is composed by 1312 aminoacids and it is expressed ubiquitously in human tissues. To date, the function of ataxin-2 is not known. In this study, we report the characterization of an alternative splice variant of human ataxin-2. The splice transcript lacks the exon 21 and connects exon 20 to exon 22 with the same reading frame of the full length mRNA. This novel isoform of ataxin-2 is conserved in the mouse. It is named type IV to differentiate it from type II splice variant lacking exon 10 (present in human and mouse cDNAs) and from type III, lacking exon 10 and exon 11 seen in mouse. Type IV of human ataxin-2 cDNA is predicted to encode a protein of 1294 residues. Both the full length and the type IV transcript of ataxin-2 are present in several human tissues, including brain, spinal cord, cerebellum, heart and placenta. These findings allow the hypothesis that type I, II and IV of human ataxin-2 might perform different functions.


Sujet(s)
Épissage alternatif , Protéines/génétique , Séquence d'acides aminés , Animaux , Ataxines , Séquence nucléotidique , Technique de Northern , ADN complémentaire/composition chimique , ADN complémentaire/génétique , Femelle , Humains , Souris , Données de séquences moléculaires , Protéines de tissu nerveux , ARN/génétique , ARN/métabolisme , Analyse de séquence d'ADN , Similitude de séquences d'acides aminés , Distribution tissulaire
15.
Circ Res ; 88(3): 319-24, 2001 Feb 16.
Article de Anglais | MEDLINE | ID: mdl-11179200

RÉSUMÉ

cAMP-dependent protein kinase is anchored to discrete cellular compartments by a family of proteins, the A-kinase anchor proteins (AKAPs). We have investigated in vivo and in vitro the biological effects of the expression of a prototypic member of the family, AKAP75, on smooth muscle cells. In vitro expression of AKAP75 in smooth muscle cells stimulated cAMP-induced transcription, increased the levels of the cyclin-dependent kinase-2 inhibitor p27(kip1), and reduced cell proliferation. In vivo expression of exogenous AKAP75 in common carotid arteries, subjected to balloon injury, significantly increased the levels of p27(kip1) and inhibited neointimal hyperplasia. Both the effects in smooth muscle cells in vitro and in carotid arteries in vivo were specifically dependent on the amplification of cAMP-dependent protein kinase (PKA) signals by membrane-bound PKA, as indicated by selective loss of the AKAP75 biological effects in mutants defective in the PKA anchor domain or by suppression of AKAP effects by the PKA-specific protein kinase inhibitor. These data indicate that AKAP proteins selectively amplify cAMP-PKA signaling in vitro and in vivo and suggest a possible target for the inhibition of the neointimal hyperplasia after vascular injury.


Sujet(s)
Protéines adaptatrices de la transduction du signal , Protéines de transport/métabolisme , Protéines du cycle cellulaire , Division cellulaire/physiologie , Cyclic AMP-Dependent Protein Kinases/métabolisme , Muscles lisses vasculaires/métabolisme , Protéines suppresseurs de tumeurs , 8-Bromo AMP cyclique/pharmacologie , Protéines d'ancrage aux protéines kinases A , Animaux , Artères carotides/composition chimique , Artères carotides/anatomopathologie , Protéines de transport/génétique , Division cellulaire/effets des médicaments et des substances chimiques , Cellules cultivées , Chloramphenicol O-acetyltransferase/effets des médicaments et des substances chimiques , Chloramphenicol O-acetyltransferase/génétique , Chloramphenicol O-acetyltransferase/métabolisme , Cyclic AMP-Dependent Protein Kinases/effets des médicaments et des substances chimiques , Inhibiteur p27 de kinase cycline-dépendante , ADN/biosynthèse , ADN/effets des médicaments et des substances chimiques , ADN recombiné , Techniques de transfert de gènes , Immunohistochimie , Protéines associées aux microtubules/analyse , Muscles lisses vasculaires/cytologie , Muscles lisses vasculaires/effets des médicaments et des substances chimiques , Plasmides/génétique , Rats , Rat Wistar , Protéines de fusion recombinantes/effets des médicaments et des substances chimiques , Protéines de fusion recombinantes/génétique , Protéines de fusion recombinantes/métabolisme , Transduction du signal/effets des médicaments et des substances chimiques , Facteurs temps , Tunique intime/composition chimique , Tunique intime/anatomopathologie , Tunique moyenne/composition chimique , Tunique moyenne/anatomopathologie
16.
J Biol Chem ; 276(15): 11487-95, 2001 Apr 13.
Article de Anglais | MEDLINE | ID: mdl-11139572

RÉSUMÉ

Activation of the cAMP-dependent protein kinase A (PKA) pathway may induce cAMP-response element-binding protein (CREB) phosphorylation either directly or via cross-talk mechanisms with other signal transduction pathways. In this study, we have investigated in striatal primary cultures the mechanism by which activation of the cAMP/PKA-dependent pathway leads to CREB phosphorylation via the extracellular signal-regulated kinase (ERK)-dependent pathway. We have found that PKA-induced CREB phosphorylation and CREB-dependent transcription are mediated by calcium (Ca(2+)) release from intracellular stores and are blocked by inhibitors of the protein kinase C and ERK pathways. This mechanism appears to be mediated by the small G-protein Rap1, whose activation appears to be primed by PKA-induced Ca(2+) release but not further induced by direct or indirect PKA- or protein kinase C-dependent phosphorylation. These results suggest that, in striatal neurons, intracellular Ca(2+) release, Rap1, and ERK pathway play a crucial role in the PKA-induced CREB phosphorylation and CREB-dependent transcription.


Sujet(s)
Calcium/métabolisme , Corps strié/métabolisme , Cyclic AMP-Dependent Protein Kinases/métabolisme , Mitogen-Activated Protein Kinases/métabolisme , Neurones/métabolisme , Protéines nucléaires/métabolisme , Transactivateurs/métabolisme , Animaux , Protéine CBP , Corps strié/cytologie , AMP cyclique/métabolisme , Activation enzymatique , Phosphorylation , Rats , Rat Sprague-Dawley , Transcription génétique
17.
Biochem Biophys Res Commun ; 272(3): 816-21, 2000 Jun 16.
Article de Anglais | MEDLINE | ID: mdl-10860836

RÉSUMÉ

The expansion of CAG repeats is the genetic defect underlying eight neurodegenerative diseases. A common feature of these disorders is the presence of intracellular aggregates in neuronal cells. It is still unclear the significance of these cellular inclusions in the neurodegenerative process, since cell death without aggregate formation has been reported. We have constructed a synthetic fusion protein containing 17 or 43 CAG repeats and the green fluorescent protein that recapitulates the features of CAG-expanded alleles. Expression of 43, but not 17 CAG repeats results in formation of nuclear aggregates in human neuroblastoma cells. Moreover, the normal allele (17 CAG) is sequestered in the inclusion bodies. The presence of nuclear inclusions tightly correlates with apoptosis in cells expressing the protein encoding 43 CAG repeats. Cells harboring nuclear aggregates stop proliferation and undergo apoptosis. Moreover, the inhibition of protein degradation pathway increases intracellular aggregates and cell death. These data indicate that intranuclear aggregates induce apoptosis and suggest that the degradation of unfolded proteins improves cell survival.


Sujet(s)
Apoptose , Corps d'inclusion/anatomopathologie , Neuroblastome/anatomopathologie , Peptides/métabolisme , Séquences répétées d'acides aminés/physiologie , Allèles , Division cellulaire , Noyau de la cellule/métabolisme , Noyau de la cellule/anatomopathologie , Survie cellulaire , Cysteine endopeptidases/métabolisme , Cytoplasme/métabolisme , Cytoplasme/anatomopathologie , Humains , Corps d'inclusion/métabolisme , Microscopie de fluorescence , Complexes multienzymatiques/métabolisme , Neuroblastome/métabolisme , Peptides/composition chimique , Peptides/génétique , Proteasome endopeptidase complex , Liaison aux protéines , Protéines de fusion recombinantes/composition chimique , Protéines de fusion recombinantes/génétique , Protéines de fusion recombinantes/métabolisme , Séquences répétées d'acides aminés/génétique , Facteurs temps , Transfection , Expansion de trinucléotide répété/génétique , Cellules cancéreuses en culture
18.
J Biol Chem ; 275(1): 303-11, 2000 Jan 07.
Article de Anglais | MEDLINE | ID: mdl-10617619

RÉSUMÉ

cAMP signals are received and transmitted by multiple isoforms of cAMP-dependent protein kinases (PKAs), typically determined by their specific regulatory subunits. We describe changes in the cAMP signal transduction pathway during cell cycle progression in synchronized rat thyroid cells. Both PKA type II (PKAII) localization and nuclear cAMP signaling are significantly modified during G(0) and G(1)-S transitions. G(1) is characterized by PKA activation and amplified cAMP signal transduction. This is associated with a decrease in the concentration of RI and RII regulatory subunits and enhanced anchoring of PKAII to the Golgi-centrosome region. Just prior to S, the cAMP pathway is depressed. Up-regulation of the pathway by exogenous cAMP in G(1) inhibited the subsequent decay of the Cdk inhibitor p27 and delayed the onset of S phase. Forced translocation of endogenous PKAII to the cytosol down-regulated cAMP signaling, advancing the timing of p27 decay and inducing premature exit from G(1). These data indicate that membrane-bound PKA amplifies the transduction of cAMP signals in G(1) and that the length of G(1) is influenced by cAMP-PKA.


Sujet(s)
Protéines du cycle cellulaire , Cycle cellulaire/physiologie , Cyclic AMP-Dependent Protein Kinases/métabolisme , AMP cyclique/métabolisme , Glande thyroide/cytologie , Protéines suppresseurs de tumeurs , Animaux , Transport biologique , Compartimentation cellulaire , Noyau de la cellule/enzymologie , Cyclic AMP-Dependent Protein Kinase Type II , Cyclic AMP-Dependent Protein Kinases/isolement et purification , Inhibiteur p27 de kinase cycline-dépendante , Kinases cyclines-dépendantes/métabolisme , Cytosol/enzymologie , Régulation négative , Phase G1/physiologie , Membranes/enzymologie , Protéines associées aux microtubules/métabolisme , Rats , Transduction du signal
19.
Cell Growth Differ ; 11(12): 649-54, 2000 Dec.
Article de Anglais | MEDLINE | ID: mdl-11149600

RÉSUMÉ

Thyroid transcription factor 1 (TTF1) is a nuclear homeodomain protein that binds to and activates the promoters of several thyroid-specific genes, including that of the thyroglobulin gene (pTg). These genes are also positively regulated by thyroid-stimulating hormone/cyclic AMP (cAMP)/protein kinase A (PKA) signaling. We asked whether PKA directly activates TTF1. We show that cAMP/PKA activates pTg and a synthetic target promoter carrying TTF1 binding site repeats in several cell types. Activation depends on TTF1. Phosphopeptide mapping indicates that TTF1 is constitutively phosphorylated at multiple sites, and that cAMP stimulated phosphorylation of one site, serine 337, in vivo. However, alanine substitution at this residue or at all sites of phosphorylation did not reduce PKA activation of pTg. Thus, PKA stimulates TTF1 transcriptional activity in an indirect manner, perhaps by recruiting to or removing from the target promoter another regulatory factor(s).


Sujet(s)
Cyclic AMP-Dependent Protein Kinases/métabolisme , Protéines nucléaires/métabolisme , Régions promotrices (génétique) , Thyroglobuline/génétique , Facteurs de transcription/métabolisme , Transcription génétique , Alanine/composition chimique , Animaux , Cellules COS , Lignée cellulaire , Milieux de culture sans sérum , AMP cyclique/métabolisme , Relation dose-effet des médicaments , Activation enzymatique , Cellules HeLa , Humains , Mutagenèse dirigée , Mutation , Cellules PC12 , Phosphorylation , Plasmides/métabolisme , Tests aux précipitines , Rats , Facteur-1 de transcription de la thyroïde , Activation de la transcription , Transfection
20.
J Biol Chem ; 274(10): 6546-52, 1999 Mar 05.
Article de Anglais | MEDLINE | ID: mdl-10037748

RÉSUMÉ

cAMP signals are received and transmitted by multiple isoforms of cAMP-dependent protein kinases, typically determined by their specific regulatory subunits. In the brain the major regulatory isoform RIIbeta and the RII-anchor protein, AKAP150 (rat) or 75 (bovine), are differentially expressed. Cortical neurons express RIIbeta and AKAP75; conversely, granule cerebellar cells express predominantly RIalpha and RIIalpha. Cortical neurons accumulate PKA catalytic subunit and phosphorylated cAMP responsive element binding protein very efficiently into nuclei upon cAMP induction, whereas granule cerebellar cells fail to do so. Down-regulation of RIIbeta synthesis by antisense oligonucleotides inhibited cAMP-induced nuclear signaling in cortical neurons. Expression in cerebellar granule cells of RIIbeta and AKAP75 genes by microinjection of specific expression vectors, markedly stimulated cAMP-induced transcription of the lacZ gene driven by a cAMP-responsive element promoter. These data indicate that the composition of PKA in cortical and granule cells underlies the differential ability of these cells to transmit cAMP signals to the nucleus.


Sujet(s)
Protéines adaptatrices de la transduction du signal , Protéines de transport , Noyau de la cellule/métabolisme , Cervelet/métabolisme , Cortex cérébral/métabolisme , Cyclic AMP-Dependent Protein Kinases/métabolisme , AMP cyclique/métabolisme , Protéines/métabolisme , Transduction du signal , Protéines d'ancrage aux protéines kinases A , Animaux , Cervelet/cytologie , Cortex cérébral/cytologie , Neurones/métabolisme , Neurones/ultrastructure , Isoformes de protéines/métabolisme , Rats
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...